Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion%–%Deal Analysis from GlobalData
Summary
GlobalData’s medical equipment report, “Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion” provides key insights on the deal. The report provides analysis and impact on the global medical devices market as a result of the deal. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
Reasons to buy
Summary
GlobalData’s medical equipment report, “Endo Pharmaceuticals to Buy American Medical Systems for $2.9 Billion” provides key insights on the deal. The report provides analysis and impact on the global medical devices market as a result of the deal. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Deal overview of the acquisition of American Medical Systems by Endo Pharmaceuticals.
- Strategic rationale behind the deal including analysis on the impact of the deal on the industry and on both the companies.
- Company profiles of Endo Pharmaceuticals and American Medical Systems.
- SWOT Analysis of both Endo Pharmaceuticals and American Medical Systems.
Reasons to buy
- Understand the strategy behind one of the most significant deals in the medical device industry.
- Identify the reasoning behind the trend of pharmaceutical businesses moving into medical device businesses.
- Explore possible repercussions on the market dynamics of AMS’s urology business.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 ENDO PHARMACEUTICALS TO BUY AMERICAN MEDICAL SYSTEMS FOR $2.9 BILLION
2.1 Summary
2.2 Deal Overview
2.3 Deal Impact
2.4 Strategic Rationale
2.4.1 Diversification of Revenue towards Medical Devices Business for Endo Pharmaceuticals
2.4.2 Strengthened Urology Segment through Integrated Products Offerings to Drive Revenues for Both Companies
2.4.3 Cost Synergies to Mutually Benefit Both Companies
2.4.4 AMS provides Endo Pharmaceuticals a Strong Market Positioning with Leading Marketed Products and an Innovative Pipeline
2.5 Company Profiles
2.5.1 American Medical Systems
2.5.2 Endo Pharmaceuticals
3 APPENDIX
3.1 Research Methodology
3.2 Secondary Research
3.3 Primary Research
3.4 Models
3.5 Forecasts
3.6 Expert Panels
3.7 GlobalData Consulting
3.8 Contact Us
3.9 Disclaimer 11
LIST OF TABLES
Table 1: Endo Pharmaceuticals and American Medical Systems, Revenue Contribution, 2010
Table 2: AMS, Market Share (%), The US
Table 3: AMS, Marketed Products, 2010
Table 4: Endo Pharmaceuticals, Marketed Products, 2011 7
LIST OF FIGURES
Figure 1: Endo Pharmaceuticals and American Medical Systems, Revenue Contribution, 2010
Figure 2: American Medical Systems, SWOT Analysis, 2010
Figure 3: Endo Pharmaceuticals, SWOT Analysis, 2010 7
1.1 List of Tables
1.2 List of Figures
2 ENDO PHARMACEUTICALS TO BUY AMERICAN MEDICAL SYSTEMS FOR $2.9 BILLION
2.1 Summary
2.2 Deal Overview
2.3 Deal Impact
2.4 Strategic Rationale
2.4.1 Diversification of Revenue towards Medical Devices Business for Endo Pharmaceuticals
2.4.2 Strengthened Urology Segment through Integrated Products Offerings to Drive Revenues for Both Companies
2.4.3 Cost Synergies to Mutually Benefit Both Companies
2.4.4 AMS provides Endo Pharmaceuticals a Strong Market Positioning with Leading Marketed Products and an Innovative Pipeline
2.5 Company Profiles
2.5.1 American Medical Systems
2.5.2 Endo Pharmaceuticals
3 APPENDIX
3.1 Research Methodology
3.2 Secondary Research
3.3 Primary Research
3.4 Models
3.5 Forecasts
3.6 Expert Panels
3.7 GlobalData Consulting
3.8 Contact Us
3.9 Disclaimer 11
LIST OF TABLES
Table 1: Endo Pharmaceuticals and American Medical Systems, Revenue Contribution, 2010
Table 2: AMS, Market Share (%), The US
Table 3: AMS, Marketed Products, 2010
Table 4: Endo Pharmaceuticals, Marketed Products, 2011 7
LIST OF FIGURES
Figure 1: Endo Pharmaceuticals and American Medical Systems, Revenue Contribution, 2010
Figure 2: American Medical Systems, SWOT Analysis, 2010
Figure 3: Endo Pharmaceuticals, SWOT Analysis, 2010 7
